Browse by Research Category

Peptides studied for their effects on cellular aging, telomere biology, growth hormone restoration, and age-related tissue decline.

Host defense peptides and synthetic analogs investigated for antibacterial, antiviral, and antifungal activity.

Compounds studied for bone density, cartilage repair, and joint tissue regeneration—from FDA-approved options to preclinical candidates.

Neuroprotective and nootropic peptides investigated for cognitive enhancement, neurodegeneration, and brain injury recovery.

Peptides in cancer research—tumor-targeting sequences, anti-angiogenic compounds, and immune checkpoint modulators.

Peptides studied for blood pressure regulation, cardiac tissue repair, and vascular function.

GHRPs, GHRH analogs, and ghrelin mimetics—the largest and most commercially active peptide research category.

Compounds investigated for IBD, intestinal permeability, mucosal healing, and GI tissue repair.

Peptides studied for hair follicle stimulation, androgenetic alopecia, and scalp health.

Thymic peptides, immunomodulators, and immune-restoring compounds—from Soviet-era thymalin to modern clinical candidates.

BPC-157, TB-500, and beyond—peptides studied for tendon, ligament, muscle, and wound healing.

Nine ultrashort peptides—two to four amino acids—developed from Vladimir Khavinson’s organ-extract research. Thymic, pineal, and vascular bioregulators with decades of Russian clinical history.

Peptides investigated for muscle growth, fat loss, athletic performance, and metabolic optimization.

Peptides for sexual function, hormonal signaling, and reproductive health—including FDA-approved bremelanotide.

Copper peptides, collagen stimulators, and cosmeceutical compounds studied for skin aging, scarring, and rejuvenation.

Growth hormone secretagogues, pineal peptides, and stress-modulating compounds studied for sleep architecture and HPA axis regulation.

Melanocortin receptor agonists—from the original melanotan research to FDA-approved afamelanotide.

Peptides investigated for retinal degeneration, macular disease, and corneal healing.

GLP-1 agonists, dual and triple receptor agonists, and investigational metabolic peptides—the most active pharmaceutical peptide category.